Mednax Inc
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric … Read more
Mednax Inc (MD) - Total Assets
Latest total assets as of September 2025: $2.20 Billion USD
Based on the latest financial reports, Mednax Inc (MD) holds total assets worth $2.20 Billion USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Mednax Inc - Total Assets Trend (1994–2024)
This chart illustrates how Mednax Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Mednax Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Mednax Inc's total assets of $2.20 Billion consist of 29.7% current assets and 70.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $229.94 Million | 10.7% |
| Accounts Receivable | $272.60 Million | 12.7% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $78.44 Million | 3.6% |
| Intangible Assets | $11.60 Million | 0.5% |
| Goodwill | $1.24 Billion | 57.7% |
Asset Composition Trend (1994–2024)
This chart illustrates how Mednax Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Mednax Inc's current assets represent 29.7% of total assets in 2024, a decrease from 84.7% in 1994.
- Cash Position: Cash and equivalents constituted 10.7% of total assets in 2024, down from 36.5% in 1994.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 57.0% of total assets, an increase from 0.0% in 1994.
- Asset Diversification: The largest asset category is goodwill at 57.7% of total assets.
Mednax Inc Competitors by Total Assets
Key competitors of Mednax Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
Mednax Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Mednax Inc generates 0.94x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Mednax Inc is currently not profitable relative to its asset base.
Mednax Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.83 | 1.42 | 3.49 |
| Quick Ratio | 1.83 | 1.42 | 3.49 |
| Cash Ratio | 0.87 | 0.28 | 0.00 |
| Working Capital | $324.65 Million | $ 155.13 Million | $ 1.11 Billion |
Mednax Inc - Advanced Valuation Insights
This section examines the relationship between Mednax Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.01 |
| Latest Market Cap to Assets Ratio | 0.76 |
| Asset Growth Rate (YoY) | -3.0% |
| Total Assets | $2.15 Billion |
| Market Capitalization | $1.63 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Mednax Inc's assets below their book value (0.76 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Mednax Inc's assets decreased by 3.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Mednax Inc (1994–2024)
The table below shows the annual total assets of Mednax Inc from 1994 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $2.15 Billion | -3.02% |
| 2023-12-31 | $2.22 Billion | -5.45% |
| 2022-12-31 | $2.35 Billion | -13.76% |
| 2021-12-31 | $2.72 Billion | -18.68% |
| 2020-12-31 | $3.35 Billion | -19.25% |
| 2019-12-31 | $4.15 Billion | -30.14% |
| 2018-12-31 | $5.93 Billion | +1.15% |
| 2017-12-31 | $5.87 Billion | +9.89% |
| 2016-12-31 | $5.34 Billion | +17.42% |
| 2015-12-31 | $4.55 Billion | +26.00% |
| 2014-12-31 | $3.61 Billion | +18.34% |
| 2013-12-31 | $3.05 Billion | +10.87% |
| 2012-12-31 | $2.75 Billion | +21.02% |
| 2011-12-31 | $2.27 Billion | +11.53% |
| 2010-12-31 | $2.04 Billion | +20.62% |
| 2009-12-31 | $1.69 Billion | +12.86% |
| 2008-12-31 | $1.50 Billion | +14.90% |
| 2007-12-31 | $1.30 Billion | +14.77% |
| 2006-12-31 | $1.14 Billion | +26.07% |
| 2005-12-31 | $900.40 Million | +14.14% |
| 2004-12-31 | $788.89 Million | +9.94% |
| 2003-12-31 | $717.59 Million | +10.62% |
| 2002-12-31 | $648.68 Million | +13.19% |
| 2001-12-31 | $573.10 Million | +76.48% |
| 2000-12-31 | $324.73 Million | -3.01% |
| 1999-12-31 | $334.80 Million | +23.68% |
| 1998-12-31 | $270.70 Million | +37.55% |
| 1997-12-31 | $196.80 Million | +23.77% |
| 1996-12-31 | $159.00 Million | +127.47% |
| 1995-12-31 | $69.90 Million | +244.33% |
| 1994-12-31 | $20.30 Million | -- |